Skip to main content
. 2017 Sep 14;14(5):5791–5800. doi: 10.3892/ol.2017.6942

Figure 4.

Figure 4.

Nomogram for predicting 8- and 5-year DFS in patients with clear cell renal cell carcinoma. (A) Nomogram for predicting clinical outcomes integrating T stage, Fuhrman nuclear grade, necrosis, ECOG PS and tumor CTR1 expression. (B) Calibration plot for predicted and observed 8-year DFS rate. (C) Calibration plot for predicted and observed 5-year DFS rate. Grey line, ideal model; vertical bars, 95% confidence interval. DFS, disease-free survival; ECOG PS, Eastern Cooperative Oncology Group performance status; CTR1, copper transporter 1.